Financial - Credit Services
Compare Stocks
2 / 10Stock Comparison
IX vs BN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
IX vs BN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Credit Services | Asset Management |
| Market Cap | $36.71B | $104.40B |
| Revenue (TTM) | $2.87T | $77.66B |
| Net Income (TTM) | $439.78B | $1.31B |
| Gross Margin | 41.8% | 40.0% |
| Operating Margin | 11.5% | 39.9% |
| Forward P/E | 0.1x | 16.7x |
| Total Debt | $6.28T | $263.42B |
| Cash & Equiv. | $1.21T | $16.24B |
IX vs BN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ORIX Corporation (IX) | 100 | 251.3 | +151.3% |
| Brookfield Corporat… (BN) | 100 | 273.1 | +173.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IX vs BN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.89, yield 2.2%
- Rev growth 2.1%, EPS growth 3.1%
- Lower volatility, beta 0.89, current ratio 1.85x
BN is the clearest fit if your priority is long-term compounding.
- 308.9% 10Y total return vs IX's 172.9%
- Efficiency ratio 0.0% vs IX's 0.3% (lower = leaner)
- Efficiency ratio 0.0% vs IX's 0.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.1% NII/revenue growth vs BN's -9.7% | |
| Value | Lower P/E (0.1x vs 16.7x) | |
| Quality / Margins | Efficiency ratio 0.0% vs IX's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 0.89 vs BN's 1.57, lower leverage | |
| Dividends | 2.2% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +69.0% vs BN's +25.5% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs IX's 0.3% |
IX vs BN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IX vs BN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
IX leads this category, winning 3 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
IX is the larger business by revenue, generating $2.87T annually — 37.0x BN's $77.7B. IX is the more profitable business, keeping 12.2% of every revenue dollar as net income compared to BN's 1.7%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.87T | $77.7B |
| EBITDAEarnings before interest/tax | $717.3B | $32.1B |
| Net IncomeAfter-tax profit | $439.8B | $1.3B |
| Free Cash FlowCash after capex | $0 | -$2.8B |
| Gross MarginGross profit ÷ Revenue | +41.8% | +40.0% |
| Operating MarginEBIT ÷ Revenue | +11.5% | +39.9% |
| Net MarginNet income ÷ Revenue | +12.2% | +1.7% |
| FCF MarginFCF ÷ Revenue | +41.1% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +74.6% | +73.1% |
Valuation Metrics
BN leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 16.9x trailing earnings, IX trades at a 100% valuation discount to BN's 9999.0x P/E. On an enterprise value basis, BN's 8.5x EV/EBITDA is more attractive than IX's 14.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $36.7B | $104.4B |
| Enterprise ValueMkt cap + debt − cash | $69.2B | $351.6B |
| Trailing P/EPrice ÷ TTM EPS | 16.90x | 9999.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.08x | 16.69x |
| PEG RatioP/E ÷ EPS growth rate | 3.18x | — |
| EV / EBITDAEnterprise value multiple | 14.79x | 8.53x |
| Price / SalesMarket cap ÷ Revenue | 2.00x | 1.34x |
| Price / BookPrice ÷ Book value/share | 1.42x | 0.66x |
| Price / FCFMarket cap ÷ FCF | 4.86x | — |
Profitability & Efficiency
IX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
IX delivers a 9.7% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $1 for BN. IX carries lower financial leverage with a 1.51x debt-to-equity ratio, signaling a more conservative balance sheet compared to BN's 1.59x. On the Piotroski fundamental quality scale (0–9), IX scores 6/9 vs BN's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.7% | +0.8% |
| ROA (TTM)Return on assets | +2.5% | +0.3% |
| ROICReturn on invested capital | +2.4% | +5.6% |
| ROCEReturn on capital employed | +2.5% | +7.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.51x | 1.59x |
| Net DebtTotal debt minus cash | $5.08T | $247.2B |
| Cash & Equiv.Liquid assets | $1.21T | $16.2B |
| Total DebtShort + long-term debt | $6.28T | $263.4B |
| Interest CoverageEBIT ÷ Interest expense | 3.88x | 1.64x |
Total Returns (Dividends Reinvested)
Evenly matched — IX and BN each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IX five years ago would be worth $22,040 today (with dividends reinvested), compared to $18,928 for BN. Over the past 12 months, IX leads with a +69.0% total return vs BN's +25.5%. The 3-year compound annual growth rate (CAGR) favors BN at 30.5% vs IX's 27.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +12.6% | -0.1% |
| 1-Year ReturnPast 12 months | +69.0% | +25.5% |
| 3-Year ReturnCumulative with dividends | +106.9% | +122.1% |
| 5-Year ReturnCumulative with dividends | +120.4% | +89.3% |
| 10-Year ReturnCumulative with dividends | +172.9% | +308.9% |
| CAGR (3Y)Annualised 3-year return | +27.4% | +30.5% |
Risk & Volatility
Evenly matched — IX and BN each lead in 1 of 2 comparable metrics.
Risk & Volatility
IX is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than BN's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BN currently trades 93.8% from its 52-week high vs IX's 89.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 1.57x |
| 52-Week HighHighest price in past year | $37.04 | $49.57 |
| 52-Week LowLowest price in past year | $19.90 | $36.47 |
| % of 52W HighCurrent price vs 52-week peak | +89.6% | +93.8% |
| RSI (14)Momentum oscillator 0–100 | 66.9 | 62.5 |
| Avg Volume (50D)Average daily shares traded | 430K | 5.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
IX is the only dividend payer here at 2.24% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $54.40 |
| # AnalystsCovering analysts | — | 9 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | — |
| Dividend StreakConsecutive years of raises | 1 | 1 |
| Dividend / ShareAnnual DPS | $116.24 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.9% | 0.0% |
IX leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BN leads in 1 (Valuation Metrics). 2 tied.
IX vs BN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is IX or BN a better buy right now?
For growth investors, ORIX Corporation (IX) is the stronger pick with 2.
1% revenue growth year-over-year, versus -9. 7% for Brookfield Corporation (BN). ORIX Corporation (IX) offers the better valuation at 16. 9x trailing P/E (0. 1x forward), making it the more compelling value choice. Analysts rate Brookfield Corporation (BN) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IX or BN?
On trailing P/E, ORIX Corporation (IX) is the cheapest at 16.
9x versus Brookfield Corporation at 9999. 0x. On forward P/E, ORIX Corporation is actually cheaper at 0. 1x.
03Which is the better long-term investment — IX or BN?
Over the past 5 years, ORIX Corporation (IX) delivered a total return of +120.
4%, compared to +89. 3% for Brookfield Corporation (BN). Over 10 years, the gap is even starker: BN returned +308. 9% versus IX's +172. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IX or BN?
By beta (market sensitivity over 5 years), ORIX Corporation (IX) is the lower-risk stock at 0.
89β versus Brookfield Corporation's 1. 57β — meaning BN is approximately 75% more volatile than IX relative to the S&P 500. On balance sheet safety, ORIX Corporation (IX) carries a lower debt/equity ratio of 151% versus 159% for Brookfield Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — IX or BN?
By revenue growth (latest reported year), ORIX Corporation (IX) is pulling ahead at 2.
1% versus -9. 7% for Brookfield Corporation (BN). On earnings-per-share growth, the picture is similar: ORIX Corporation grew EPS 3. 1% year-over-year, compared to -99. 8% for Brookfield Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IX or BN?
ORIX Corporation (IX) is the more profitable company, earning 12.
2% net margin versus 1. 7% for Brookfield Corporation — meaning it keeps 12. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BN leads at 39. 9% versus 11. 5% for IX. At the gross margin level — before operating expenses — IX leads at 41. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IX or BN more undervalued right now?
On forward earnings alone, ORIX Corporation (IX) trades at 0.
1x forward P/E versus 16. 7x for Brookfield Corporation — 16. 6x cheaper on a one-year earnings basis.
08Which pays a better dividend — IX or BN?
In this comparison, IX (2.
2% yield) pays a dividend. BN does not pay a meaningful dividend and should not be held primarily for income.
09Is IX or BN better for a retirement portfolio?
For long-horizon retirement investors, ORIX Corporation (IX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
89), 2. 2% yield, +172. 9% 10Y return). Brookfield Corporation (BN) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IX: +172. 9%, BN: +308. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IX and BN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IX is a mid-cap deep-value stock; BN is a mid-cap quality compounder stock. IX pays a dividend while BN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.